comparemela.com

Latest Breaking News On - Quarter for zentalis pharmaceuticals - Page 1 : comparemela.com

Insider Selling: Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) CFO Sells 9,597 Shares of Stock

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) CFO Cam Gallagher sold 9,597 shares of the business’s stock in a transaction on Friday, May 31st. The shares were sold at an average price of $11.98, for a total transaction of $114,972.06. Following the transaction, the chief financial officer now owns 633,680 shares in the company, […]

Stifel-nicolaus
Nasdaq
Zentalis-pharmaceuticals-inc
Zentalis-pharmaceuticals-stock-performance
Vanguard-group-inc
Tower-research-capital
Sg-americas-securities
Quarter-for-zentalis-pharmaceuticals
Zentalis-pharmaceuticals-company-profile
Charles-schwab-investment-management-inc
York-mellon-corp
News-ratings-for-zentalis-pharmaceuticals-daily

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) CFO Sells $114,972.06 in Stock

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) CFO Cam Gallagher sold 9,597 shares of the business’s stock in a transaction dated Friday, May 31st. The shares were sold at an average price of $11.98, for a total value of $114,972.06. Following the sale, the chief financial officer now owns 633,680 shares in the company, […]

China
Stifel-nicolaus
Tower-research-capital
Oneascent-financial-services
Exchange-traded-concepts
Zentalis-pharmaceuticals-trading-down
Quarter-for-zentalis-pharmaceuticals
Zentalis-pharmaceuticals-inc
Nasdaq
China-universal-asset-management-co
Quest-partners
News-ratings-for-zentalis-pharmaceuticals-daily

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Insider Diana Hausman Sells 3,356 Shares

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Insider Diana Hausman Sells 3,356 Shares
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

China
Stifel-nicolaus
Diana-hausman
Zentalis-pharmaceuticals-company-profile
Zentalis-pharmaceuticals
China-universal-asset-management-co
News-ratings-for-zentalis-pharmaceuticals-daily
Wealth-management
Nasdaq
Zentalis-pharmaceuticals-trading-down
Institutional-investors-weigh-in-on-zentalis-pharmaceuticals
Quarter-for-zentalis-pharmaceuticals

abrdn plc Makes New Investment in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL)

abrdn plc purchased a new stake in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 40,156 shares of the company’s stock, valued at approximately $608,000. abrdn plc owned about 0.06% of Zentalis Pharmaceuticals as […]

Melissab-epperly
Exchange-commission
Hermes-inc
Insider-transactions-at-zentalis-pharmaceuticals
News-ratings-for-zentalis-pharmaceuticals-daily
Eventide-asset-management
Sectoral-asset-management-inc
Quarter-for-zentalis-pharmaceuticals
Vanguard-group-inc
Zentalis-pharmaceuticals-stock-down
Nasdaq

Kennedy Capital Management LLC Has $3.14 Million Stock Position in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL)

Kennedy Capital Management LLC boosted its position in shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Free Report) by 2.7% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 156,475 shares of the company’s stock after purchasing an additional 4,178 shares during the […]

Melissab-epperly
Quarter-for-zentalis-pharmaceuticals
Zentalis-pharmaceuticals-stock
Zentalis-pharmaceuticals
Ameritas-investment-partners-inc
Nasdaq
Zentalis-pharmaceuticals-inc
Principal-financial-group-inc
Zentalis-pharmaceuticals-company-profile
Exchange-commission
Insider-activity-at-zentalis-pharmaceuticals

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.